The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Status:
Completed
Trial end date:
2017-11-11
Target enrollment:
Participant gender:
Summary
The investigators multicenter randomized open-labelled study will investigate the efficacy of
an everolimus based immunosuppression in reducing total native kidney volume in kidney
recipients with autosomal dominant polycystic kidney disease compared to a calcineurin
inhibitor-based immunosuppression.